Lataa...
Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer
Pancreatic cancer is associated with poor prognosis due to limited therapeutic options. Excision repair cross-complementing 3 (ERCC3) is an important member of nucleotide excision repair (NER) that is overexpressed in some cancers and may be regarded as a poor prognostic factor. Yet, its role in pan...
Tallennettuna:
| Julkaisussa: | J Cancer |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ivyspring International Publisher
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8040713/ https://ncbi.nlm.nih.gov/pubmed/33854616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.54576 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|